Cypress Bioscience, Ramius LLC deal

Cypress shareholder Ramius extended its previously announced unsolicited tender offer to acquire the 90.1% of Cypress it does not already own for $4.25 per share in cash to Dec. 10 from Nov. 10. Ramiu...